|
Clinical feature of patients with CoV infection
|
SARS-CoV-2
|
MERS-CoV
|
SARS-CoV
|
|---|
|
Study (n)
|
Reports (n)
|
Pregnancies (n)
|
Pooled % (95%-CI)
|
Study (n)
|
Reports (n)
|
Pregnancies (n)
|
Pooled % (95%-CI)
|
Study (n)
|
Reports (n)
|
Pregnancies (n)
|
Pooled % (95%-CI)
|
|---|
|
Fever
|
19
|
575
|
870
|
66.1% [56.1–79.8]
|
6
|
9
|
12
|
75% [30.2–88.9]
|
7
|
32
|
33
|
96.9% [84.6–100]
|
|
Cough
|
18
|
458
|
869
|
52.7% [34.7–67.7]
|
4
|
7
|
9
|
77.8% [40.1–97.5]
|
6
|
21
|
26
|
80.8% [61.4–93.6]
|
|
Fatigue
|
8
|
192
|
634
|
30.3% [14.4–49.6]
|
1
|
1
|
2
|
50% [1.2–99.2]
|
–
|
–
|
–
|
–
|
|
Dyspnea
|
7
|
49
|
303
|
16.2% [7.6–22.3]
|
1
|
1
|
2
|
50% [1.4–99.6]
|
1
|
9
|
10
|
90% [55.3–100]
|
|
Myalgia
|
5
|
61
|
293
|
20.8% [7.5–27.8]
|
2
|
3
|
8
|
37.5 [9.3–76.2]
|
2
|
16
|
22
|
72.7% [50.1–89.8]
|
|
Shortness of Breath
|
6
|
186
|
586
|
31.7% [18.2–41.5]
|
1
|
1
|
2
|
50% [1.4–99.6]
|
3
|
9
|
24
|
37.5% [19.2–59.6]
|
|
Sore throat
|
6
|
78
|
668
|
11.7% [5.1–29.1]
|
–
|
–
|
–
|
–
|
2
|
5
|
22
|
22.7% [8.7–45.5]
|
|
Chill
|
3
|
44
|
480
|
9.2% [4.7–71.1]
|
–
|
–
|
–
|
–
|
3
|
15
|
23
|
65.2% [43.1–84.8]
|
|
Headache
|
5
|
88
|
674
|
13.1% [8.5–33.2]
|
1
|
1
|
2
|
50% [1.4–99.6]
|
4
|
15
|
24
|
62.5% [41.3–81.9]
|
|
Muscle pain
|
3
|
67
|
628
|
10.7% [4.9–25.4]
|
–
|
–
|
–
|
–
|
2
|
2
|
11
|
18.2% [3.2–35.9]
|
|
Diarrhea
|
9
|
41
|
753
|
5.4% [2.2–10.3]
|
1
|
1
|
2
|
50% [1.4–99.6]
|
2
|
3
|
22
|
13.6% [6.6–48.7]
|
|
Abdominal pain
|
2
|
5
|
64
|
7.8% [3.5–17.1]
|
1
|
1
|
2
|
50% [1.4–99.6]
|
–
|
–
|
–
|
–
|
|
Pneumonia
|
21
|
368
|
517
|
71.2% [68.6–95.8]
|
4
|
5
|
7
|
71.4% [29.5–96.2]
|
5
|
8
|
9
|
88.9% [52.1–100]
|
|
Laboratory finding
|
|
Leukocytosis
|
6
|
27
|
95
|
28.4% [20.1–39.6]
|
–
|
–
|
–
|
–
|
3
|
10
|
24
|
41.7% [22.1–63.2]
|
|
Leukopenia
|
6
|
43
|
95
|
45.3% [35.4–56.3]
|
–
|
–
|
–
|
–
|
3
|
14
|
24
|
58.3% [37.2–78.3]
|
|
Lymphocytosis
|
12
|
8
|
70
|
11.4% [5.5–21.3]
|
–
|
–
|
–
|
–
|
4
|
3
|
24
|
12.5% [3.2–32.8]
|
|
Lymphocytopenia
|
13
|
92
|
146
|
63% [55.7–71.4]
|
1
|
1
|
1
|
100% [3.3–100]
|
4
|
20
|
24
|
83.3% [63.1–95.5]
|
|
ALT↑
|
3
|
9
|
48
|
18.8% [9.5–33.7]
|
2
|
1
|
3
|
33.3% [1.6–91.3]
|
2
|
2
|
8
|
25% [3.3–65.3]
|
|
AST↑
|
3
|
8
|
48
|
16.7% [7.2–30.5]
|
2
|
1
|
3
|
33.3% [1.6–91.3]
|
2
|
2
|
8
|
25% [3.3–65.3]
|
|
LDH↑
|
3
|
8
|
23
|
34.8% [16.2–57.9]
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
|
C-reactive protein ↑
|
11
|
80
|
143
|
55.9% [47.4–64.2]
|
1
|
1
|
1
|
100% [3.3–100]
|
1
|
1
|
1
|
100% [3.3–100]
|
- AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase
